JPRN-UMIN000036101已完成未知
A study for safety evaluation of 12-weeks consumption of the food containing algae - A study for safety evaluation of 12-weeks consumption of the food containing algae
CPCC Company Limited0 个研究点目标入组 40 人开始时间: 2020年3月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects who are likely to cause allergies against test food especially algae and/or seaweeds. 2) Subjects who are given continuous treatment by taking medicines. 3) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ). 4) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period. 5) Subjects who excessive alcohol intake. 6) Subjects who have moderate symptom of pollen allergy. 7) Subjects who are participating the other clinical tests. Subjects who participated within three month prior to the current study and/or who plan to participate the other clinical tests. 8) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 9) Subjects who donated over 400mL blood and/or blood components within the last three month to the current study. 10) Females who donated over 400mL blood and/or blood components within the last four month to the current study. 11) Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 12) Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 13) Others who have been determined ineligible by principal investigator or sub-investigator.
研究者
相似试验
已完成
不适用
A study for safety evaluation of 12-weeks consumption of the drink containing indigestible dextrin.Healthy adultJPRN-UMIN000018446CPCC Company Limited30
进行中（未招募）
不适用
Safety Study of the iBalance Axial Knee Realignment System (AKRFX)ACTRN12607000422426iBalance Medical Inc.25
进行中（未招募）
1 期
A 12 week study to assess the efficacy and safety of AF-219 in patients with long term coughEUCTR2015-005064-42-GBAfferent Pharmaceuticals, Inc.253
已完成
3 期
A clinical trial to study safety and tolerance of the drug called Pregabalin as an add on treatment in pediatric patients aged 1 to 16 years of age with partial seizures, and pediatric and adult patients aged 5 â?? 65 years with tonic-clonic seizuresCTRI/2016/08/007183Pfizer Limited8
进行中（未招募）
1 期
A 12-week study to test lung function in people with COPD.EUCTR2013-004548-44-PLGlaxoSmithKline Research & Development Ltd1,582